直 Japanese PDF Font
  • Our Professionals
  • Our Work
  • Our Insights
  • Offices
  • Firm
  • Careers
Finnegan
  • Articles & Books
    • Ad Law Buzz Blog
    • At the PTAB Blog
    • European IP Blog
    • Federal Circuit IP Blog
    • INCONTESTABLE® Blog
    • Prosecution First Blog
  • Events & Webinars
  • IP Updates
  • Podcasts
    • AI + Finnegan
    • AI + Copyright
    • AI + Patent
    • AI + Privacy
    • AI + Trade Secrets
    • AI + Trademark
  • Unified Patent Court (UPC) Hub

Federal Circuit IP Blog

Spotlight on Upcoming Oral Arguments – April 2019

March 29, 2019

Authored and Edited by Katherine T. Leonard; Caitlin E. Fowler; Elizabeth D. Ferrill

Monday, April 1, 2019

Hyosung TNS Inc. v. ITC, No. 17-2563, Courtroom 402

In this appeal from the ITC, Hyosung seeks reversal of the ITC’s exclusion order for Hyosung’s ATMs.  Diebold filed a complaint with the ITC alleging that Hyosung’s ATMs infringe the claims of U.S. Patent Nos. 6,082,616 (“the ’616 patent”) and 7,832,631 (“the ’631 patent”).  The ITC instituted an investigation based on Diebold’s complaint.  At the conclusion of the investigation, the ITC issued its final opinion finding that Hyosung’s ATMs infringe the patents and that Diebold satisfied the “domestic industry” requirement under 19 U.S.C. § 1337(a)(3).

Hyosung argues that the ITC erred in concluding that the “domestic industry” requirement was met for the ’631 patent.  Specifically, Hyosung argues that Diebold failed to demonstrate that significant or substantial expenditures related to the ’631 patent.  Hyosung contends that Diebold’s failure to show any significant expenditures after 2010 is evidence that any domestic industry that might have existed no longer exists today.  The ITC and Diebold both argue that “domestic industry” requirement can be satisfied by investments made before the filing date of the complaint.  Thus, the ITC and Diebold contend that Diebold’s investment in research and development, as well as Diebold’s continued investments in the products that practice the claimed inventions, are sufficient to satisfy the “domestic industry” requirement.

Wednesday, April 3, 2019

Mayne Pharma International Pty v. Merck Sharp & Dohme Corp., No. 18-1593, Courtroom 402

Mayne appeals a PTAB Final Written Decision finding the challenged claims unpatentable on the grounds that the PTAB improperly instituted Merck’s IPR petition.  Merck filed an IPR petition within one year of being served with the complaint alleging infringement in a related district court proceeding.  The petition did not include Merck & Co., Inc. (“MCI”), Merck’s parent corporation, as a real-party-in-interest.  Eighteen months later, Merck corrected its real-party-in-interest identification to include MCI.

Mayne argues that Merck’s petition was time barred as a result of Merck’s untimely identification of MCI as a real-party-in-interest.  Merck argues that the USPTO rules require that the “filing date” assigned to the petition must correspond to the date of Merck’s correction.  Merck argues that had the PTAB followed the USPTO rules, the filing date would have been beyond the one-year window, thus rendering the petition time-barred.  Merck argues that the purpose of the “real party in interest” disclosure is to give notice to Board members of potential conflicts and disclose parties bound by an IPR’s estoppel effects. Merck further argues that because the petition already alerted the Board to MCI’s connection to Merck and that MCI had agreed in a related district court action to be bound by the IPR’s result, the Board acted within its discretion in allowing Merck to retroactively add MCI to its disclosures and not pushing the filing date.

In Re Branded LLC, No. 18-1828, Courtroom 402

This appeal arises from a TTAB decision rejecting the mark “TWEEDS” as being generic for “shirts and sweaters.”  Branded LLC had previously registered the mark “TWEEDS” for “shirts and sweaters.”  This mark was inadvertently cancelled due to failure to file renewal paperwork before the current application for the same mark was filed.

Branded argues that in rejecting the new application, the Board did not give the appropriate weight and presumption of validity to the prior registration of the word “TWEEDS” for the same goods.  By rejecting the mark as generic without providing evidence of how public perception of “TWEEDS” has changed, Branded argues that the Board mounted a collateral attack on a mark protected under sections 14 and 15 of the Lanham Act 15 U.S.C. §§ 1064 and 1065.  In rebuttal, the USPTO first argues that Branded did not offer the prior registration as evidence. The USPTO further argues that, even if Branded had offered the prior registration as evidence, the TTAB was not required to give weight to the mark’s prior registration because registrability of a mark is determined on the basis of facts existing at the time registration is sought, not at a previous time years’ past.

Monday, April 8, 2019

Inspired Development Group v. Inspired Products Group, LLC, No. 18-1616, Courtroom 201

Inspired Development Group (“Inspired Development”) appeals from a Southern District of Florida decision finding that it had subject matter jurisdiction over the action pursuant to 28 U.S.C. § 1338(a) because the claims arose under federal patent law.

Inspired Development brought suit against Inspired Products Group (“Inspired Products”) seeking to recover unpaid patent license royalties.  Inspired Development’s complaint included claims for breach of contract, unjust enrichment, and promissory estoppel.  Inspired Development argues that the district court erred in finding federal subject matter jurisdiction under 28 U.S.C. § 1338(a) because there was no necessarily raised, actually disputed, and substantial issue of federal patent law.  Rather, Inspired Development argues that the breach of contract and unjust enrichment claims arose under state-law.  Inspired Products argues that Inspired Developments’ claims raised substantial issues of infringement, validity, and inventorship.  Specifically, Inspired Products argues that Inspired Development’s unjust enrichment claim requires proof of infringement and thus it “necessarily raised” a question of patent law.

Tags

Spotlight on Upcoming Oral Arguments

Related Practices

Appeals, Issues, and Legal Strategy

Federal Circuit and Supreme Court Appeals

Contacts

Elizabeth D. Ferrill
Partner
Washington, DC
+1 202 408 4445
Email

Copyright © 2019 Finnegan, Henderson, Farabow, Garrett & Dunner, LLP. 


DISCLAIMER: Although we wish to hear from you, information exchanged in this blog cannot and does not create an attorney-client relationship. Please do not post any information that you consider to be personal or confidential. If you wish for Finnegan, Henderson, Farabow, Garrett & Dunner, LLP to consider representing you, in order to establish an attorney-client relationship you must first enter a written representation agreement with Finnegan. Contact us for additional information. One of our lawyers will be happy to discuss the possibility of representation with you. Additional disclaimer information. 

Related Insights

Conference

7th International Conference on Biofuels and Bioenergy

June 25-26, 2026

Edinburgh

Conference

17th Summit on Biosimilars & Innovator Biologics

June 2-3, 2026

New York

At the PTAB Blog

Consistency Is Key – USPTO Issues Three New Informative Decisions

May 29, 2026

At the PTAB Blog

Discretion All the Way Down: USPTO Uses a Discretionary IPR Denial to Justify a    
§ 325(d) EPR Denial

May 28, 2026

At the PTAB Blog

IPR and PGR Statistics for Final Written Decisions Issued in March and April 2026

May 26, 2026

At the PTAB Blog

Before the Holding, the Message: Director Squires Uses Magnolia Medical to Outline PTAB Discretionary Denial Policy Changes

May 20, 2026

Conference

19th Annual Forum on Pharma & Biotech Patent Litigation in Europe

May 19-20, 2026

Amsterdam

Articles

COPPA’s Amended Rule Is Now in Full Effect: What Operators Need to Know

May 15, 2026

INCONTESTABLE® Blog

Netflix Prevails in Copyright Infringement Suit Regarding Tiger King

May 14, 2026

Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.

  • Privacy
  • Disclaimer
  • Legal Notices
  • Fraud Alert
  • EEO Statement
  • Cookies
  • Contact Us

© 2026 Finnegan, Henderson, Farabow, Garrett & Dunner, LLP